For the group of malignant melanocytic lesions, we included primary melanomas (MM) as well as distant metastases of melanomas (MET) in order to see if there are differences in SEC62 expression between primary tumor tissue and tissue with a presumably higher metastatic potential. This evidence concerns the gene SEC62 and Miyoshi myopathy.